Exelon Corporation recently acquired Pepco Holdings. Approximately 15,000 new members will join the Exelon Corporation Prescription Drug Plan effective January 1, 2017. OptumRx ID cards are being issued to these new members. There are no changes to the pharmacy processing information and all members will be recognized as members of the Exelon plan. Pepco Holdings members participate in the Select 90 retail program. No changes to the existing Exelon plans.

*Please see attached PDF for more information.

Effective January 1, 2017, CMS will require Medicare plan sponsors to implement a soft point of sale (POS) reject when an opioid prescription is presented following the initiation of buprenorphine for the treatment of opioid use disorder. An enhancement to the Drug-Drug Interaction (DDI) cDUR edit will be turned on to reject opioid claims when a member has a recent history of treatment with buprenorphine or buprenorphine containing products indicated for opioid dependence.

*Please see the attached PDF for more information.